C22H18N4OS
386.5 g/mol
APIWarning
Axitinib
CAS319460-85-0
Category
API
Compound Class
Other
Primary Use
Pharmaceutical Raw Material
Axitinib is a small molecule compound that acts as a tyrosine kinase inhibitor, primarily used in pharmaceutical manufacturing. It has shown activity in preclinical and clinical studies involving certain tumor types.
pharmaceutical raw material for oncology researchcompound for kinase inhibition studiesresearch agent in cancer models
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 319460-85-0
Related Compounds
ReferenceSame Category
Bunolol hydrochloride
CAS31969-05-8
pharmaceutical raw material
ReferenceSame Category
Azacitidine
CAS320-67-2
pharmaceutical raw material
ReferenceSame Category
Nafronyl oxalate
CAS3200-06-4
pharmaceutical raw material
ReferenceSame Category
Aclidinium bromide
CAS320345-99-1
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
H341Suspected of causing genetic defects
H361Suspected of damaging fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
Identifiers
IUPAC Name
N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
InChIKey
RITAVMQDGBJQJZ-FMIVXFBMSA-N
SMILES
CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4
Synonyms (29)
- Axitinib (JAN/USAN)
- 4ag8
- 4agc
- AG-013736;Axitinib
- AXITINIB [MART.]
- Axitinib
- Axitinib (Standard)
- Axitinib, >=98% (HPLC)
- Axitinib,AG-013736
- Inlyta
- Inlyta (TN)
- axitinibum